Buy Aurobindo Pharma; target of Rs 554: Geojit
 Geojit is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 554 in its research report dated March 02, 2023.
 
 Latest News from Moneycontrol.com

 Geojit is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 554 in its research report dated March 02, 2023.
 
 Latest News from Moneycontrol.com
 Your Technology Source, Your Technology Team
Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more
Contact Us: contact@crwetech.com
 
Our content delivery solution through CRWE WORLD, CRWE Press Release and CRWE Tube gives corporations and businesses a vehicle to expand their exposure
 CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform
 
 
Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!
Contact Us: contact@crweworld.com